Premium
Novel ADAMTS‐13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura
Author(s) -
TAO Z.,
ANTHONY K.,
PENG Y.,
CHOI H.,
NOLASCO L.,
RICE L.,
MOAKE J. L.,
DONG J.F.
Publication year - 2006
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2006.02098.x
Subject(s) - adamts13 , adamts , thrombotic thrombocytopenic purpura , von willebrand factor , thrombospondin , medicine , disintegrin , immunology , mutation , platelet , metalloproteinase , gene , biology , genetics , matrix metalloproteinase
Summary. Background: Thrombotic thrombocytopenic purpura (TTP) is associated with congenital and acquired deficiency of ADAMTS‐13, a metalloprotease that cleaves von Willebrand factor (VWF) and reduces its adhesive activity. Mutations throughout the ADAMTS13 gene have been identified in congenital TTP patients, most of whom have initial episodes during infancy or in early childhood. Patients and methods: We report the case of an adult male who was diagnosed with idiopathic thrombocytopenic purpura at age 34, and with TTP 14 years later. The patient was compound heterozygous for an 18 bp in‐frame deletion (C365del) in the disintegrin domain and a point mutation of R1060W in the seventh thrombospondin domain of the ADAMTS‐13 gene. Conclusions: In vitro studies found that C365del and R1060W severely impair ADAMTS‐13 synthesis in transfected Hela cells, whereas the deletion mutant also failed to cleave VWF under static and flow conditions.